Relationship between Dosage Accuracy and the Success of Dengue Fever Therapy in Children
DOI:
https://doi.org/10.37287/ijghr.v7i6.302Keywords:
antipyretic, dengue fever, dosage accuracy, electrolyte therapyAbstract
Dengue Hemorrhagic Fever (DHF) is a disease transmitted through the bite of the Aedes aegypti mosquito. In 2024, DHF cases in Indonesia reached 1,010 cases, most of which occurred in children, with a mortality rate of 34 cases. DHF therapy generally uses electrolyte fluids and antipyretics. Accurate dosage is crucial for achieving successful therapy and maintaining normal temperature and hematocrit. This study aims to determine patient characteristics, the accuracy of antipyretic and fluid therapy dosages, and the relationship between the accuracy of antipyretic drug dosages and fluid therapy with therapeutic success in pediatric DHF patients at the Inpatient Unit of DKT Slamet Riyadi Hospital, Surakarta. This study is non-experimental with a cross-sectional observational approach. Data were collected and analyzed by reviewing the medical records of DHF patients during the 2021-2023 period, resulting in a total sample of 30 pediatric patients. The data collected was then processed to analyze drug therapy given to pediatric DHF patients, with a focus on evaluating drug rationality based on appropriate dosage categories. The results of the analysis are presented in a table to show the percentage of dengue fever medication use in pediatric patients at DKT Slamet Riyadi Surakarta Hospital, along with relevant analysis. The results show that all patients (100%) were aged 1-5 years, with 56.67% male and 43.33% female. The accuracy of antipyretic (paracetamol) and fluid therapy (RL) dosages was 86.66% accurate. The Chi-Square statistical test showed a p-value (<0.05), indicating a relationship between dosage accuracy and the success of dengue fever therapy in pediatric patients.
References
Ardlianti, R., Bagas, W., & Rachim, W. (2022). Parenteral Fluid Drops in Dengue Fever Patients: An Analytical Observational Study at Sultan Agung Islamic Hospital, Semarang, January to December 2019. Relationship Between Hematocrit Value and Drip Rate of Parenteral Fluid in DHF Patients (Analytic. Jurnal Ilmiah Sultan Agung , 00 , 364–374.
Aryu, C. (2016). Epidemiology, Pathogenesis and Risk Factors of Transmission. Aspirator , 2 (2), 119–120.
Central Java Provincial Health Office. (2021). Dengue Hemorrhagic Fever Data . Central Java Provincial Health Office.
Dwi Arymbhi Sanjaya, Budiartha Siada, Herleeyana Meriyani, Rr. Asih Juanita, & Made Elvenia Ambara Damayanti. (2025). Evaluation of Therapy Provision for Dengue Fever Patients at Bali Provincial General Hospital. Journal of Pharmaceutical Science and Clinical Research , 10 (1), 338–354.
Hartini, IS, Prasetyo, EY, Kusumaratni, DA, Pratama, Y., & Prodyanatasari, A. (2024). Rationality of the Use of Analgesic And Antipyretic Drugs in Dengue Hemorrhagic Fever Patients In A Hospital Environment. Jurnal Wiyata , 11 (2), 148–157.
Heryana, A. (2020). Chi-Square Test. In Esa Unggul University (Issue May). https://doi.org/10.13140/RG.2.2.23266.15047
Indriyani, DPR, & Gustawan, IW (2020). Clinical manifestations and management of grade 1 dengue fever: a literature review. Medical Science Digest , 11 (3), 1015–1019. https://doi.org/10.15562/ism.v11i3.847
Lesar, E., BSjosep, W., & R. Pinantoan, O. (2020). Overview of Community Knowledge and Practices Regarding Dengue Fever Vector Control in Touure Village, Minahasa Regency in 2020. Public Health , 9 (7), 168–175.
Lestari, PA, Fajar, NA, Windusari, Y., Novrikasari, & Sunarsih, E. (2023). Environmental Health Factors Influencing the Incidence of Dengue Fever (DHF) in Endemic Areas: A Systematic Literature Review. Health Information: Research Journal , 15 (3), 1–10.
Melissa G, Tansil; Novie H, Rampengan; Rocky, W. (2021). Risk Factors for Dengue Shock Syndrome in Dengue Hemorrhagic Fever. Biomedical Journal (Jbm) , 13 (2), 161. https://doi.org/10.35790/jbm.13.2.2021.31816
Melly, A., & Anggraini, D. (2022). Clinical Aspects and Laboratory Examination for the Diagnosis of Dengue Hemorrhagic Fever. Scientific Journal , 1 (1), 68–76. https://doi.org/10.56260/sciena.v1i1.13
Indonesian Minister of Health. (2021). National Guidelines for Medical Services for the Management of Dengue Infections in Children and Adolescents. Indonesian Ministry of Health , 67 , 1–67.
Meriska, N., Susanti, R., & Nurmainah. (2019). Evaluation of Dengue Hemorrhagic Fever (DHF) Therapy Management in Pediatric Patients at the Inpatient Unit of Sultan Syarif Mohamad Alkadrie Regional Hospital in 2019. Journal of Pharmacy Students, Faculty of Medicine, UNTAN , 5 (1), 1–13.
Nusi, DT, Danes, VR, & Moningka, MEW (2013). Comparison of Body Temperature Based on Measurements Using a Mercury Thermometer and a Digital Thermometer in Fever Patients at Kandou General Hospital, Manado. Jurnal E-Biomedik , 1 (1), 190–196. https://doi.org/10.35790/ebm.1.1.2013.1616
Pipin Supenah, Muhammad Ibnu Ubaidillah, Ikhwani Ikhwani, & Diyanah Alifia Ramadhan. (2021). Description of Hematocrit Values in Dengue Hemorrhagic Fever Patients at RSUD 45 Kuningan. Journal of Science and Health , 5 (2), 75–83. https://doi.org/10.57214/jusika.v5i2.507
Podung, GCD, Tatura, SNN, & Mantik, MFJ (2021). Risk Factors for Dengue Shock Syndrome in Dengue Hemorrhagic Fever. Jurnal Biomedik (Jbm) , 13 (2), 161. https://doi.org/10.35790/jbm.13.2.2021.31816
Putri, LA, Harahap, NRA, & Hasmar, WN (2022). Overview of Treatment Rationality in Pediatric Patients with Dengue Hemorrhagic Fever (DF) at a Private Hospital in East Bekasi in 2020. Jurnal Mitra Kesehatan , 4 (2), 130–136. https://doi.org/10.47522/jmk.v4i2.142
Rita, Amyasfedfwopru (2021). Biomedicine . PUBLISHER CV. Eureka Media Aksara.
Rizky, MA, Primadiamanti, A., & Hidayaturahmah, R. (2024). Rationality of Using Dengue Fever Medication in Inpatient Pediatric Patients at Pertamina Bintang Amin Hospital, Bandar Lampung. Malahayati Pharmaceutical Journal , 7 (1), 105–117.
Rosa dwi wahyuni. (2017). Dengue Hemorrhagic Fever In The Inpatient Room Of Rsi Siti Khadijah Palembang In 2017 Palembang in 2017. The data was take based on medical record, the used data were .
Sari, DF (2020). Overview of Paracetamol Use in Dengue Fever Inpatients at Nur Hidayah Hospital, Bantul, October-December 2020. Akrsfindo , 1 (1), 25–29.
Sholihah, SH, Retnowati, E., Elvina, N., & Fitria, L. (2022). Rationality of Using Paracetamol in Pediatric Patients Aged 1-12 Years of Fever in Hospital Rationality of Using Paracetamol in Pediatric Patients Aged 1-12 Years of Dengue Hemorrhagic Fever in Inpatient Unit . 1571–1576.
Sumampouw, OJ (2020). Epidemiology of Dengue Hemorrhagic Fever in Minahasa Regency, North Sulawesi. Sam Ratulangi Journal of Public Health , 1 (March), 1–18.
Suryoputri, MW, Mustikaningtias, I., & Maharani, L. (2020). Monitoring of Narrow Therapeutic Index Drug Levels Through Estimation of Drug Levels in Blood in Inpatients at Prof. Dr. Margono Soekarjo Regional General Hospital, Purwokerto. Indonesian Journal of Clinical Pharmacy , 9 (2), 105. https://doi.org/10.15416/ijcp.2020.9.2.105
Yunilda Rosa, Masnir Alwi, & Monica Julianti. (2019). Rationale for Treatment of Dengue Fever Patients in the Inpatient Ward of Siti Khadijah Hospital, Palembang, 2017. Jurnal Kesehatan: Jurnal Ilmiah Multi Sciences , 9 (01), 61–66. https://doi.org/10.52395/jkjims.v9i01.156
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
